YESTAR HEALTH announced its interim results, with profit attributable to owners of the company amounting to HKD 5.761 million, a year-on-year decrease of 99.47%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, YESTAR HEALTH announced its mid-term results for 2025, with continuing operations revenue of approximately HKD 803 million, a year-on-year decrease of 36.99%; profit attributable to the company's owners was HKD 5.761 million, a year-on-year decrease of 99.47%; earnings per share were 0.25 cents. The announcement stated that both revenue and gross profit margin declined simultaneously, mainly due to the impact of China's centralized procurement policy on the medical segment (which is the group's main source of income)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments